Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)
暂无分享,去创建一个
R. Orlowski | B. Amini | Sheeba K. Thomas | J. Shah | D. Weber | E. Manasanch | S. Iyer | K. Patel | Hans C. Lee | R. J. Johnson | Ashley N. Morphey | Brandon N. Crumpton | Lei Feng | Suzanne Phillips | Carla P Miller